PRECIGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.41 USD | +0.71% |
|
+6.02% | +5.22% |
| Apr. 24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
| Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
Chart calendar Precigen, Inc.
8a96a6096a.aTqc2vM-7AJUq183S3kGRf4PBszk7XHxwOvQP1N49u4.IUrVj4Z7iERm3QVxAzx0M7p_a77chwbJtt2ZByEToaQIXfO2o1icRjjqBg~812efcebb1b470ff111fe1360bc54667
Upcoming events on Precigen, Inc.
Past events on Precigen, Inc.
| 2024-03-25 01:00 pm | Investor Meeting - Cantor Fitzgerald |
| 2024-03-19 04:30 pm | Q4 2023 Earnings Call |
| 2024-03-19 04:05 pm | Q4 2023 Earnings Release |
| 2024-02-13 03:20 pm | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-10 08:15 pm | JPMorgan Healthcare Conference |
| 2023-12-06 03:00 pm | JMP Securities Hematology and Oncology Summit |
| 2023-11-15 10:55 am | Stifel Healthcare Conference |
| 2023-11-09 04:55 pm | Q3 2023 Earnings Release |
| 2023-10-26 02:00 pm | Cantor AML Virtual Conference - Panel |
| 2023-10-11 06:30 pm | Cell & Gene Meeting on the Mesa Conference |
| 2023-09-26 04:55 pm | Cantor Global Healthcare Conference |
| 2023-08-09 08:30 am | Q2 2023 Earnings Call |
| 2023-08-09 08:00 am | Q2 2023 Earnings Release |
| 2023-06-08 09:00 am | Annual General Meeting |
| 2023-06-07 03:15 pm | BIO International Convention |
| 2023-06-05 02:15 pm | American Society of Clinical Oncology Conference - Abstract #5590 |
| 2023-06-03 09:00 am | American Society of Clinical Oncology Conference - Abstract #2628 |
| 2023-05-10 08:00 am | Q1 2023 Earnings Call |
| 2023-05-10 08:00 am | Q1 2023 Earnings Release |
| 2023-04-17 09:00 am | American Association for Cancer Research Meeting |
Past dividends on Precigen, Inc.
| 2015-06-08 | 0.162203 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 90,7 106 -14.2% | 103 104 -1.07% | 104 102 1.86% | 26,9 57,9 -53.5% | 6,23 6,64 -6.23% | 5,59 |
|
EBITDA Million USD | Released Forecast Spread | -149 -154 3.57% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -173 -181 3.94% | -85,7 -117 26.69% | -78,8 -81,8 3.65% | -75,7 -68,4 -10.75% | -99,8 -85,3 -16.97% | -90,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -209 -196 -6.37% | -104 -133 21.67% | -96,9 -98,1 1.23% | -80,0 -72,3 -10.55% | -96,4 -82,4 -16.99% | -89,9 |
|
Net income Million USD | Released Forecast Spread | -322 -195 -64.94% | -171 -139 -22.91% | -92,2 -95,8 3.76% | 28,3 -24,8 214.05% | -95,9 -82,5 -16.26% | -89,6 |
|
EPS USD | Released Forecast Spread | -2,09 -1,27 -64.73% | -1,02 -0,86 -18.2% | -0,47 -0,49 3.8% | 0,14 0,14 0% | -0,39 -0,36 -9.29% | -0,34 |
| Announcement Date | 02/03/20 | 01/03/21 | 01/03/22 | 06/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,2 22,2 8.89% | 32,0 23,3 37.63% | 2,91 22,5 -87.08% | 16,7 35,3 -52.65% | 1,76 6,21 -71.61% | 1,85 2,97 -37.61% | 1,77 2,18 -18.94% | 1,38 1,98 -30.18% | 1,23 1,70 -27.76% | 1,48 | 1,48 | 1,48 | 1,48 | 16,8 |
|
EBIT Million USD | Released Forecast Spread | -20,5 -22,8 10.04% | -17,4 -21,9 20.48% | -24,2 -27,0 10.39% | -7,61 -24,2 68.56% | -21,8 -18,7 -16.44% | -23,5 -23,5 -0.12% | -21,1 -24,4 13.48% | -20,9 -19,0 -9.92% | -34,2 -19,9 -71.96% | -22,4 | -22,6 | -22,9 | -23,2 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,0 -26,2 4.67% | -19,3 -26,4 26.86% | -26,1 -29,7 11.95% | -7,69 -27,7 72.22% | -22,2 -19,2 -15.34% | -22,8 -23,7 3.84% | -20,4 -24,4 16.58% | -19,8 -18,9 -4.85% | -33,4 -19,2 -73.58% | -22,1 | -22,3 | -22,7 | -23,0 | |
|
Net income Million USD | Released Forecast Spread | -25,0 -26,2 4.63% | -19,3 -26,4 27.08% | -17,6 -29,7 40.62% | 87,4 -27,7 415.47% | -22,2 -19,2 -15.38% | -22,7 -23,7 4.08% | -20,3 -24,4 16.84% | -19,8 -18,9 -4.81% | -33,1 -19,2 -71.85% | -22,1 | -22,3 | -22,7 | -23,0 | |
|
EPS USD | Released Forecast Spread | -0,13 -0,14 4.66% | -0,10 -0,13 21.57% | -0,09 -0,15 37.93% | 0,44 -0,14 425.93% | -0,11 -0,10 -10% | -0,10 -0,10 3.22% | -0,08 -0,10 20.41% | -0,08 -0,08 -3.24% | -0,13 -0,08 -68.83% | -0,09 | -0,08 | -0,08 | -0,08 | -0,05 |
| Announcement Date | 01/03/22 | 09/05/22 | 08/08/22 | 09/11/22 | 06/03/23 | 10/05/23 | 09/08/23 | 09/11/23 | 19/03/24 | - | - | - | - | - |
More events
Past sector events for Precigen, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PGEN Stock
- Calendar Precigen, Inc.
